‘4-in-1’ treatment for young children living with HIV approved in South Africa

The South African Health Products Regulatory Authority has approved a sweet-tasting, heat-stable, 4-in-1 fixed-dose combination of four antiretroviral treatments developed by Cipla and DNDi